All stock lists
NervGen Pharma Corp. (NASDAQ:NGEN)
CA · Delayed Price · Currency is USD
Also listed: NGENF, NGEN.VHealthcare · Biotechnology
$1.64+$0.01 (+0.61%)
Market cap
$176M
Insider Score
Health Score
Analyst consensus
Listed since
Feb 8, 2021
Website
Insider Score
––Not scored
NGEN Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
NGEN analyst forecast
Best analysts covering NGEN
No firm covering NGEN has a call old enough to have finished a 1Y holding period yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
NGEN analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-14 |
NGEN earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-04-02 | -$0.06 | -$0.26 | $5K | $0 |
| 2026-05-18 | -$0.07 | -$0.01 | $5K | $0 |
| 2026-08-13 | -$0.06 | -$0.37 | $5K | $0 |
| 2026-11-12 | -$0.10 | -$0.10 | $0 | $0 |
| 2027-04-08Upcoming | -$0.12 | — | $0 | — |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.